| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation elongation factor activity | 7.24e-05 | 20 | 82 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 1.82e-04 | 27 | 82 | 3 | GO:0051139 | |
| GeneOntologyCellularComponent | eukaryotic translation elongation factor 1 complex | 9.75e-05 | 4 | 85 | 2 | GO:0005853 | |
| GeneOntologyCellularComponent | condensed chromosome | 2.55e-04 | 307 | 85 | 7 | GO:0000793 | |
| GeneOntologyCellularComponent | chromosomal region | 3.15e-04 | 421 | 85 | 8 | GO:0098687 | |
| GeneOntologyCellularComponent | lamellipodium | 3.52e-04 | 230 | 85 | 6 | GO:0030027 | |
| GeneOntologyCellularComponent | kinetochore | 8.63e-04 | 181 | 85 | 5 | GO:0000776 | |
| GeneOntologyCellularComponent | cell leading edge | 9.73e-04 | 500 | 85 | 8 | GO:0031252 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 1.15e-03 | 193 | 85 | 5 | GO:0000779 | |
| GeneOntologyCellularComponent | cytoplasmic side of lysosomal membrane | 1.44e-03 | 14 | 85 | 2 | GO:0098574 | |
| GeneOntologyCellularComponent | cytolytic granule | 1.44e-03 | 14 | 85 | 2 | GO:0044194 | |
| MousePheno | abnormal cerebellar cortex morphology | 8.37e-06 | 300 | 64 | 9 | MP:0004097 | |
| MousePheno | abnormal glial cell morphology | 2.55e-05 | 345 | 64 | 9 | MP:0003634 | |
| MousePheno | abnormal inner ear vestibular sensory neuron innervation pattern | 6.17e-05 | 3 | 64 | 2 | MP:0014490 | |
| MousePheno | abnormal cerebellum morphology | 6.49e-05 | 389 | 64 | 9 | MP:0000849 | |
| MousePheno | abnormal cerebral hemisphere morphology | HFE ARID1B EPM2A NTRK2 STON2 SORCS2 KATNIP CHD7 ARHGAP11A ZBTB18 LYST | 7.66e-05 | 599 | 64 | 11 | MP:0008540 |
| MousePheno | abnormal metencephalon morphology | 1.17e-04 | 420 | 64 | 9 | MP:0000847 | |
| MousePheno | abnormal vestibular nerve morphology | 1.23e-04 | 4 | 64 | 2 | MP:0004718 | |
| MousePheno | ventricular myocardium compact layer hypoplasia | 1.23e-04 | 4 | 64 | 2 | MP:0010640 | |
| MousePheno | abnormal cerebellar layer morphology | 1.92e-04 | 263 | 64 | 7 | MP:0009956 | |
| MousePheno | abnormal neuron number | 2.16e-04 | 456 | 64 | 9 | MP:0008946 | |
| MousePheno | abnormal CNS glial cell morphology | 2.36e-04 | 272 | 64 | 7 | MP:0000952 | |
| MousePheno | abnormal telencephalon morphology | HFE ARID1B EPM2A SPP1 NTRK2 STON2 SORCS2 KATNIP CHD7 ARHGAP11A ZBTB18 LYST | 2.72e-04 | 812 | 64 | 12 | MP:0000787 |
| MousePheno | abnormal limbic system morphology | 3.13e-04 | 378 | 64 | 8 | MP:0004166 | |
| Domain | Transl_elong_EF1A_euk/arc | 1.86e-05 | 2 | 81 | 2 | IPR004539 | |
| Domain | Transl_elong_EFTu/EF1A_C | 5.11e-04 | 8 | 81 | 2 | IPR004160 | |
| Domain | GTP_EFTU_D3 | 5.11e-04 | 8 | 81 | 2 | PF03143 | |
| Domain | G_TR_CS | 6.56e-04 | 9 | 81 | 2 | IPR031157 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 8.17e-04 | 10 | 81 | 2 | IPR009001 | |
| Domain | FERM_M | 1.04e-03 | 46 | 81 | 3 | PF00373 | |
| Domain | - | 1.25e-03 | 49 | 81 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 1.25e-03 | 49 | 81 | 3 | IPR019748 | |
| Domain | FERM_domain | 1.25e-03 | 49 | 81 | 3 | IPR000299 | |
| Domain | FERM_1 | 1.33e-03 | 50 | 81 | 3 | PS00660 | |
| Domain | FERM_2 | 1.33e-03 | 50 | 81 | 3 | PS00661 | |
| Domain | FERM_3 | 1.33e-03 | 50 | 81 | 3 | PS50057 | |
| Domain | Band_41_domain | 1.33e-03 | 50 | 81 | 3 | IPR019749 | |
| Domain | B41 | 1.33e-03 | 50 | 81 | 3 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.33e-03 | 50 | 81 | 3 | IPR014352 | |
| Domain | G_TR_1 | 1.40e-03 | 13 | 81 | 2 | PS00301 | |
| Domain | Na_H_Exchanger | 1.63e-03 | 14 | 81 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 1.63e-03 | 14 | 81 | 2 | IPR006153 | |
| Domain | EFTu-like_2 | 2.72e-03 | 18 | 81 | 2 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 2.72e-03 | 18 | 81 | 2 | PF03144 | |
| Domain | G_TR_2 | 2.72e-03 | 18 | 81 | 2 | PS51722 | |
| Domain | TF_GTP-bd_dom | 3.03e-03 | 19 | 81 | 2 | IPR000795 | |
| Domain | WD40 | 5.37e-03 | 259 | 81 | 5 | PF00400 | |
| Domain | Transl_B-barrel | 6.08e-03 | 27 | 81 | 2 | IPR009000 | |
| Domain | WD40 | 6.19e-03 | 268 | 81 | 5 | SM00320 | |
| Domain | TYR_PHOSPHATASE_1 | 6.21e-03 | 86 | 81 | 3 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 6.41e-03 | 87 | 81 | 3 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 6.41e-03 | 87 | 81 | 3 | IPR000387 | |
| Domain | RICIN | 6.53e-03 | 28 | 81 | 2 | SM00458 | |
| Domain | RICIN_B_LECTIN | 6.53e-03 | 28 | 81 | 2 | PS50231 | |
| Domain | WD40_repeat | 6.58e-03 | 272 | 81 | 5 | IPR001680 | |
| Domain | WD_REPEATS_1 | 7.20e-03 | 278 | 81 | 5 | PS00678 | |
| Domain | WD_REPEATS_2 | 7.31e-03 | 279 | 81 | 5 | PS50082 | |
| Domain | WD_REPEATS_REGION | 7.31e-03 | 279 | 81 | 5 | PS50294 | |
| Domain | Ricin_B_lectin | 7.47e-03 | 30 | 81 | 2 | IPR000772 | |
| Domain | - | 7.48e-03 | 92 | 81 | 3 | 3.90.190.10 | |
| Domain | SNF2_N | 8.47e-03 | 32 | 81 | 2 | IPR000330 | |
| Domain | SNF2_N | 8.47e-03 | 32 | 81 | 2 | PF00176 | |
| Pubmed | TPR KMT2C ARID1B AHI1 PTPN13 PAXBP1 SYNJ1 NKAPD1 TMEM131L SDF4 CHD7 CAMTA2 SLC39A10 HERC1 ERBIN SPAG5 | 7.44e-09 | 1084 | 85 | 16 | 11544199 | |
| Pubmed | 7.93e-08 | 418 | 85 | 10 | 34709266 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PTPN13 SYNJ1 ERCC6L SYNE2 ZBTB21 ANKRD26 NHS MORC3 LYST ERBIN FAM83B EEF1A1 EEF1A2 | 1.71e-07 | 861 | 85 | 13 | 36931259 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF131 RIF1 SATB1 SLC4A1AP NKAPD1 ZBTB21 CHD7 TAF2 MORC3 ARHGAP11A CASZ1 | 2.82e-07 | 608 | 85 | 11 | 36089195 |
| Pubmed | 1.64e-06 | 35 | 85 | 4 | 24515614 | ||
| Pubmed | 1.71e-06 | 453 | 85 | 9 | 29656893 | ||
| Pubmed | 2.39e-06 | 472 | 85 | 9 | 38943005 | ||
| Pubmed | 2.44e-06 | 87 | 85 | 5 | 12465718 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR ZNF131 RIF1 PTPN13 SYNJ1 ERCC6L ZBTB21 ANKRD26 ERBIN SPAG5 KNL1 EEF1A2 | 2.86e-06 | 934 | 85 | 12 | 33916271 |
| Pubmed | 3.14e-06 | 41 | 85 | 4 | 34638806 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR ZNF131 RIF1 ARID1B PAXBP1 BRCA2 SLC4A1AP CHD7 KNL1 EEF1A1 EEF1A1P5 EEF1A2 | 3.55e-06 | 954 | 85 | 12 | 36373674 |
| Pubmed | TPR SYNJ1 NTRK2 SYNE2 ZBTB21 STON2 TLN2 CHD7 SPECC1L ERBIN EEF1A1 EEF1A2 | 3.90e-06 | 963 | 85 | 12 | 28671696 | |
| Pubmed | 5.48e-06 | 277 | 85 | 7 | 30745168 | ||
| Pubmed | eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency. | 5.90e-06 | 2 | 85 | 2 | 30782564 | |
| Pubmed | SorCS2 is required for BDNF-dependent plasticity in the hippocampus. | 5.90e-06 | 2 | 85 | 2 | 27457814 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 35741005 | ||
| Pubmed | The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders. | 5.90e-06 | 2 | 85 | 2 | 30370994 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26212729 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 17825975 | ||
| Pubmed | Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients. | 5.90e-06 | 2 | 85 | 2 | 16003728 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22095224 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 38220433 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19636410 | ||
| Pubmed | Recurrent SPECC1L-NTRK fusions in pediatric sarcoma and brain tumors. | 5.90e-06 | 2 | 85 | 2 | 33144287 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 7945283 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 32347192 | ||
| Pubmed | 6.28e-06 | 15 | 85 | 3 | 8812466 | ||
| Pubmed | 8.10e-06 | 549 | 85 | 9 | 38280479 | ||
| Pubmed | RIF1 ARID1B PTPN13 SLC4A1AP PTPRZ1 SYNE2 NHS SDF4 SLC39A10 HERC1 ERBIN KNL1 | 9.25e-06 | 1049 | 85 | 12 | 27880917 | |
| Pubmed | KMT2C RIF1 PTPN13 PAXBP1 SLC4A1AP CHD7 SPECC1L TAF2 ERBIN FHIP1A CASZ1 FAM83B SEC13 EEF1A1P5 | 1.53e-05 | 1497 | 85 | 14 | 31527615 | |
| Pubmed | 1.56e-05 | 20 | 85 | 3 | 21689717 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 19559761 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 37429391 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 34611268 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 18448518 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20956301 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.96e-05 | 774 | 85 | 10 | 15302935 | |
| Pubmed | 1.96e-05 | 225 | 85 | 6 | 12168954 | ||
| Pubmed | RIF1 PTPN13 SLC30A5 ANKRD26 SPECC1L SLC39A10 CLSPN ERBIN FAM83B SEC13 | 2.02e-05 | 777 | 85 | 10 | 35844135 | |
| Pubmed | 2.52e-05 | 634 | 85 | 9 | 34591612 | ||
| Pubmed | 2.58e-05 | 486 | 85 | 8 | 20936779 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 11294870 | ||
| Pubmed | Identification of regulators of chaperone-mediated autophagy. | 3.53e-05 | 4 | 85 | 2 | 20797626 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 15013623 | ||
| Pubmed | 4.69e-05 | 263 | 85 | 6 | 34702444 | ||
| Pubmed | 5.20e-05 | 268 | 85 | 6 | 33640491 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 5.59e-05 | 398 | 85 | 7 | 35016035 | |
| Pubmed | Dynamic regulation of p53 subnuclear localization and senescence by MORC3. | 5.87e-05 | 5 | 85 | 2 | 17332504 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 38244928 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 18649364 | ||
| Pubmed | Perforin is a critical physiologic regulator of T-cell activation. | 5.87e-05 | 5 | 85 | 2 | 21606480 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 19915045 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 8626763 | ||
| Pubmed | 7.94e-05 | 421 | 85 | 7 | 36976175 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 16888816 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 9.78e-05 | 588 | 85 | 8 | 38580884 | |
| Pubmed | 1.01e-04 | 591 | 85 | 8 | 15231748 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.10e-04 | 444 | 85 | 7 | 34795231 | |
| Pubmed | 1.22e-04 | 103 | 85 | 4 | 10574462 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.26e-04 | 197 | 85 | 5 | 20811636 | |
| Pubmed | 1.55e-04 | 469 | 85 | 7 | 27634302 | ||
| Pubmed | SOCS2 Binds to and Regulates EphA2 through Multiple Mechanisms. | 1.57e-04 | 110 | 85 | 4 | 28883622 | |
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 35905187 | ||
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 18563556 | ||
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 17082189 | ||
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 28082402 | ||
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 1.75e-04 | 113 | 85 | 4 | 34474245 | |
| Pubmed | ZNF131 KMT2C RIF1 ARID1B SATB1 SYNE2 ZBTB21 CHD7 TAF2 HERC1 ERBIN SEC13 | 1.82e-04 | 1429 | 85 | 12 | 35140242 | |
| Pubmed | 1.93e-04 | 116 | 85 | 4 | 30804394 | ||
| Pubmed | 1.93e-04 | 116 | 85 | 4 | 30652415 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.10e-04 | 220 | 85 | 5 | 35785414 | |
| Pubmed | 2.40e-04 | 504 | 85 | 7 | 34432599 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 2.57e-04 | 125 | 85 | 4 | 32891193 | |
| Pubmed | ZNF131 PTPN13 PAXBP1 SLC4A1AP SYNE2 ANKRD26 TMEM131L SDF4 SLC39A10 ERBIN FAM83B EEF1A2 | 2.62e-04 | 1487 | 85 | 12 | 33957083 | |
| Pubmed | Dual-specificity phosphatase 18 modulates the SUMOylation and aggregation of Ataxin-1. | 2.62e-04 | 10 | 85 | 2 | 29852174 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.63e-04 | 361 | 85 | 6 | 30344098 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 2.69e-04 | 232 | 85 | 5 | 25515538 | |
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 3.16e-04 | 132 | 85 | 4 | 16944949 | |
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 18406329 | ||
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 21425081 | ||
| Pubmed | 3.94e-04 | 1116 | 85 | 10 | 31753913 | ||
| Pubmed | 4.33e-04 | 733 | 85 | 8 | 34672954 | ||
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 29285303 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 4.63e-04 | 146 | 85 | 4 | 23892456 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 4.96e-04 | 569 | 85 | 7 | 30639242 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 5.14e-04 | 1155 | 85 | 10 | 20360068 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 5.67e-04 | 582 | 85 | 7 | 20467437 | |
| Pubmed | A gene expression map of human chromosome 21 orthologues in the mouse. | 6.24e-04 | 158 | 85 | 4 | 12466855 | |
| Pubmed | JIP4 is a PLK1 binding protein that regulates p38MAPK activity in G2 phase. | 6.93e-04 | 16 | 85 | 2 | 26291670 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RIF1 SLC4A1AP SLC39A10 CLSPN ARHGAP11A ERBIN KNL1 EEF1A1P5 EEF1A2 | 6.99e-04 | 989 | 85 | 9 | 36424410 |
| Pubmed | 7.01e-04 | 163 | 85 | 4 | 12466854 | ||
| Pubmed | 7.14e-04 | 71 | 85 | 3 | 16829211 | ||
| Pubmed | SYNJ1 DOCK8 PTPRZ1 STON2 SORCS2 TLN2 SPECC1L ERBIN EEF1A1 SEC13 EEF1A2 | 7.20e-04 | 1431 | 85 | 11 | 37142655 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 7.30e-04 | 289 | 85 | 5 | 23752268 | |
| Pubmed | Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. | 7.33e-04 | 165 | 85 | 4 | 16107646 | |
| Pubmed | 7.67e-04 | 167 | 85 | 4 | 25659891 | ||
| Pubmed | 8.80e-04 | 18 | 85 | 2 | 2338144 | ||
| Pubmed | 8.80e-04 | 18 | 85 | 2 | 12426392 | ||
| Pubmed | 8.80e-04 | 18 | 85 | 2 | 33323119 | ||
| Pubmed | Evidence for distinct functions for human DNA repair factors hHR23A and hHR23B. | 8.80e-04 | 18 | 85 | 2 | 16712842 | |
| Interaction | FER1L6 interactions | 2.42e-06 | 7 | 84 | 3 | int:FER1L6 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 4.72e-04 | 50 | 55 | 3 | 1293 | |
| GeneFamily | WD repeat domain containing | 1.18e-03 | 262 | 55 | 5 | 362 | |
| GeneFamily | Solute carriers | 1.23e-03 | 395 | 55 | 6 | 752 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.39e-03 | 718 | 55 | 8 | 28 | |
| GeneFamily | Nucleoporins | 4.25e-03 | 32 | 55 | 2 | 1051 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | ZNF131 RIF1 PAXBP1 GALNT2 BRCA2 ERCC6L NTRK2 GZMB EMILIN2 ZNF431 MTFR2 SLC39A10 ARHGAP11A ZNF614 SPAG5 KNL1 FAM83B | 2.29e-06 | 1407 | 85 | 17 | M14427 |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 4.05e-06 | 200 | 85 | 7 | M5041 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN | 4.05e-06 | 200 | 85 | 7 | M8403 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP | 4.05e-06 | 200 | 85 | 7 | M5700 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | RIF1 AHI1 PTPN13 SLC30A5 SLC4A1AP SPP1 MYO10 SYNE2 ARHGAP11A SKAP2 KNL1 | 8.84e-06 | 656 | 85 | 11 | M18979 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.69e-05 | 180 | 85 | 6 | M8239 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH1_UP | 4.72e-05 | 199 | 85 | 6 | M5453 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 4.72e-05 | 199 | 85 | 6 | M6028 | |
| Coexpression | GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP | 4.85e-05 | 200 | 85 | 6 | M8597 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | RIF1 PAXBP1 BRCA2 SYNE2 SLC25A14 ANKRD26 CHD7 MTFR2 CLSPN ARHGAP11A SPAG5 KNL1 | 4.95e-05 | 939 | 85 | 12 | M45768 |
| Coexpression | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD | 5.56e-05 | 23 | 85 | 3 | M16409 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | RIF1 AHI1 BRCA2 PTPRZ1 CHD7 CLSPN ARHGAP11A SPAG5 KNL1 EEF1A2 | 7.02e-05 | 680 | 85 | 10 | MM456 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RIF1 SP100 PTPN13 BRCA2 MYO10 SYNE2 TMEM131L SPECC1L ARHGAP11A SKAP2 ZBTB18 | 9.97e-05 | 856 | 85 | 11 | M4500 |
| Coexpression | VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_8MO_UP | 1.42e-04 | 81 | 85 | 4 | M40892 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 1.52e-04 | 155 | 85 | 5 | M39041 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 1.56e-04 | 475 | 85 | 8 | M40979 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | SATB1 DOCK8 MYO10 SORCS2 EMILIN2 MTFR2 CLSPN ARHGAP11A LY75 SKAP2 ERBIN CASZ1 | 1.76e-04 | 1074 | 85 | 12 | M1941 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 2.13e-04 | 90 | 85 | 4 | M39250 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN | 2.60e-04 | 174 | 85 | 5 | M2996 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 2.74e-04 | 176 | 85 | 5 | M2981 | |
| Coexpression | GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 2.74e-04 | 176 | 85 | 5 | M9137 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 3.04e-04 | 180 | 85 | 5 | M2961 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | 3.10e-04 | 526 | 85 | 8 | M2520 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 3.35e-04 | 402 | 85 | 7 | MM454 | |
| Coexpression | HU_FETAL_RETINA_MULLER | 3.45e-04 | 42 | 85 | 3 | M39267 | |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN | 3.62e-04 | 187 | 85 | 5 | M34027 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 3.62e-04 | 187 | 85 | 5 | M2984 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 3.66e-04 | 290 | 85 | 6 | M45736 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_DN | 4.09e-04 | 192 | 85 | 5 | M9987 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | 4.16e-04 | 694 | 85 | 9 | M45767 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN | 4.28e-04 | 194 | 85 | 5 | M4227 | |
| Coexpression | GSE12366_GC_VS_NAIVE_BCELL_DN | 4.39e-04 | 195 | 85 | 5 | M3170 | |
| Coexpression | GSE22886_IL2_VS_IL15_STIM_NKCELL_UP | 4.49e-04 | 196 | 85 | 5 | M4514 | |
| Coexpression | ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN | 4.52e-04 | 46 | 85 | 3 | M6792 | |
| Coexpression | KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN | 4.60e-04 | 10 | 85 | 2 | M6379 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | RABEPK SP100 SLC30A5 BRCA2 ERCC6L DOCK8 SYNE2 MTFR2 CLSPN SPAG5 KNL1 | 4.62e-04 | 1023 | 85 | 11 | M17122 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 4.78e-04 | 305 | 85 | 6 | M19875 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP | 4.81e-04 | 199 | 85 | 5 | M5009 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN | 4.81e-04 | 199 | 85 | 5 | M4571 | |
| Coexpression | GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP | 4.81e-04 | 199 | 85 | 5 | M6839 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN | 4.81e-04 | 199 | 85 | 5 | M9253 | |
| Coexpression | GSE11924_TFH_VS_TH17_CD4_TCELL_UP | 4.81e-04 | 199 | 85 | 5 | M3156 | |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN | 4.92e-04 | 200 | 85 | 5 | M6372 | |
| Coexpression | GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN | 4.92e-04 | 200 | 85 | 5 | M5096 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP | 4.92e-04 | 200 | 85 | 5 | M6447 | |
| Coexpression | GSE14308_TH2_VS_TH1_DN | 4.92e-04 | 200 | 85 | 5 | M3360 | |
| Coexpression | GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP | 4.92e-04 | 200 | 85 | 5 | M7018 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 4.92e-04 | 200 | 85 | 5 | M3580 | |
| Coexpression | GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP | 4.92e-04 | 200 | 85 | 5 | M7962 | |
| Coexpression | GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP | 4.92e-04 | 200 | 85 | 5 | M9030 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN | 4.92e-04 | 200 | 85 | 5 | M9923 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_DN | 4.92e-04 | 200 | 85 | 5 | M3631 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 4.92e-04 | 200 | 85 | 5 | M7168 | |
| Coexpression | GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP | 4.92e-04 | 200 | 85 | 5 | M7206 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN | 4.92e-04 | 200 | 85 | 5 | M5603 | |
| Coexpression | GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN | 4.92e-04 | 200 | 85 | 5 | M6943 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | 5.48e-04 | 721 | 85 | 9 | M10237 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 7.63e-08 | 192 | 85 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 3.80e-07 | 232 | 85 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | RIF1 BRCA2 MYO10 PTPRZ1 NTRK2 SYNE2 STON2 ANKRD26 CHD7 CLSPN SPAG5 KNL1 | 6.76e-07 | 498 | 85 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 8.07e-07 | 186 | 85 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TPR RIF1 AHI1 BRCA2 ERCC6L PTPRZ1 SYNE2 ANKRD26 TMEM131L CHD7 LRRTM3 MTFR2 HERC1 CLSPN ZBTB18 SPAG5 KNL1 | 8.39e-07 | 1060 | 85 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RIF1 AHI1 BRCA2 SLC4A1AP MYO10 PTPRZ1 NTRK2 SYNE2 ANKRD26 TMEM131L SDF4 CHD7 CLSPN SPAG5 KNL1 | 9.52e-07 | 831 | 85 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TPR RIF1 SP100 AHI1 BRCA2 ERCC6L PTPRZ1 NTRK2 SYNE2 ANKRD26 TMEM131L CHD7 LRRTM3 MTFR2 HERC1 CLSPN ZBTB18 SPAG5 KNL1 | 2.42e-06 | 1414 | 85 | 19 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.29e-06 | 311 | 85 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.63e-06 | 179 | 85 | 7 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPR RIF1 AHI1 BRCA2 ERCC6L SLC4A1AP SPP1 MYO10 PTPRZ1 NKAPD1 SYNE2 ANKRD26 TMEM131L MTFR2 CLSPN SPAG5 KNL1 | 8.35e-06 | 1257 | 85 | 17 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPR RIF1 AHI1 BRCA2 ERCC6L SLC4A1AP SPP1 MYO10 PTPRZ1 NKAPD1 SYNE2 ANKRD26 TMEM131L CHD7 MTFR2 CLSPN SPAG5 KNL1 | 1.52e-05 | 1459 | 85 | 18 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | B cells, preB.FrD.BM, CD19+ IgM- CD45R+ CD43-, Bone marrow, avg-3 | ARID1B SLC30A5 SORCS2 TMEM131L CLSPN ARHGAP11A ZBTB18 SPAG5 KNL1 | 2.26e-05 | 383 | 85 | 9 | GSM399448_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | TPR RIF1 AHI1 BRCA2 ERCC6L NKAPD1 ZNF846 ANKRD26 TMEM131L NHS CHD7 MTFR2 CLSPN ERBIN SPAG5 KNL1 | 2.89e-05 | 1241 | 85 | 16 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | RIF1 BRCA2 SLC4A1AP MYO10 PTPRZ1 NTRK2 SYNE2 STON2 ANKRD26 NHS KATNIP CHD7 CLSPN SPAG5 | 3.34e-05 | 983 | 85 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | RIF1 SP100 AHI1 BRCA2 MYO10 PTPRZ1 NTRK2 SYNE2 STON2 ANKRD26 CHD7 CLSPN SPAG5 KNL1 | 3.57e-05 | 989 | 85 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 3.85e-05 | 410 | 85 | 9 | GSM538387_500 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 4.39e-05 | 417 | 85 | 9 | GSM399403_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RIF1 SLC4A1AP MYO10 PTPRZ1 NTRK2 SYNE2 ANKRD26 NHS CHD7 CLSPN SPAG5 | 5.86e-05 | 654 | 85 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.89e-05 | 246 | 85 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | TPR RIF1 SP100 AHI1 BRCA2 ERCC6L NKAPD1 ZNF846 ANKRD26 TMEM131L NHS CHD7 MTFR2 CLSPN ERBIN SPAG5 KNL1 | 6.08e-05 | 1468 | 85 | 17 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.71e-05 | 348 | 85 | 8 | gudmap_kidney_e10.5_UretericTip_HoxB7_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | TPR AHI1 SATB1 BRCA2 SYNJ1 MYO10 PTPRZ1 SYNE2 ANKRD26 NHS CHD7 TAF2 CLSPN ZBTB18 SPAG5 KNL1 | 9.40e-05 | 1370 | 85 | 16 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TPR RIF1 BRCA2 ERCC6L NKAPD1 ZNF846 SYNE2 ANKRD26 TMEM131L NHS CHD7 MTFR2 SLC39A10 CLSPN KNL1 | 1.21e-04 | 1252 | 85 | 15 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | TPR SP100 AHI1 PTPN13 BRCA2 MYO10 NTRK2 SYNE2 NHS CHD7 CLSPN ZBTB18 FAM83B | 1.43e-04 | 986 | 85 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 1.57e-04 | 493 | 85 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.94e-04 | 298 | 85 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 1.94e-04 | 398 | 85 | 8 | GSM399397_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 2.08e-04 | 402 | 85 | 8 | GSM605898_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.25e-04 | 137 | 85 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.41e-04 | 139 | 85 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | KMT2C RIF1 BRCA2 SYNJ1 CCNB3 SYNE2 RNF19B MIER3 ANKRD26 MORC3 HERC1 | 2.63e-04 | 776 | 85 | 11 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 2.88e-04 | 422 | 85 | 8 | GSM538357_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 3.40e-04 | 327 | 85 | 7 | GSM538380_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.48e-04 | 233 | 85 | 6 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 4.00e-04 | 336 | 85 | 7 | GSM538413_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | PTPN13 SLC30A5 SATB1 ERCC6L SPP1 SYNE2 RNF19B CHD7 CLSPN ARHGAP11A ZNF354C | 4.51e-04 | 827 | 85 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.75e-04 | 168 | 85 | 5 | gudmap_developingGonad_P2_ovary_1000_k4 | |
| CoexpressionAtlas | alpha beta T cells, T.8.TI.B16, 4- 8+ TCR+ 45+, B16 Melanoma Tumor, avg-2 | 5.94e-04 | 359 | 85 | 7 | GSM605773_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 7.55e-04 | 374 | 85 | 7 | GSM538389_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.70e-04 | 271 | 85 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.79e-04 | 376 | 85 | 7 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 7.93e-04 | 492 | 85 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 9.36e-04 | 388 | 85 | 7 | GSM538352_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | SATB1 BRCA2 ERCC6L SPP1 MYO10 SYNE2 RNF19B SORCS2 CLSPN ARHGAP11A | 9.77e-04 | 768 | 85 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | 1.04e-03 | 395 | 85 | 7 | GSM538340_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.05e-03 | 192 | 85 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.23e-09 | 197 | 85 | 8 | 47be19f595135da248469b2e21b8d88f561827b2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.57e-09 | 199 | 85 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 4.76e-09 | 200 | 85 | 8 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.80e-08 | 163 | 85 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.75e-08 | 181 | 85 | 7 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.73e-08 | 189 | 85 | 7 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.01e-08 | 190 | 85 | 7 | 185ae04c68f825cd346aa65072cc5da6a39dff4a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.01e-08 | 190 | 85 | 7 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.01e-08 | 190 | 85 | 7 | e38dc41f2e79e3bd51326581c6ebe51927edb549 | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 8.30e-08 | 191 | 85 | 7 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.24e-08 | 194 | 85 | 7 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 9.24e-08 | 194 | 85 | 7 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.24e-08 | 194 | 85 | 7 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.24e-08 | 194 | 85 | 7 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.24e-08 | 194 | 85 | 7 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 9.57e-08 | 195 | 85 | 7 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 9.90e-08 | 196 | 85 | 7 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 9.90e-08 | 196 | 85 | 7 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-07 | 197 | 85 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.03e-07 | 197 | 85 | 7 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.06e-07 | 198 | 85 | 7 | 2e669da80363163b806f23a645474d482797ae5d | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 1.06e-07 | 198 | 85 | 7 | 5c92687b853ebb00960adbef6552f9d460bc6886 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-07 | 198 | 85 | 7 | 48d39018c56ea8ba972c72af8ece10cbeb48fbc8 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type | 1.10e-07 | 199 | 85 | 7 | 87113d398585076ece86b9098781e817f8ca241b | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 1.10e-07 | 199 | 85 | 7 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-07 | 199 | 85 | 7 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 1.10e-07 | 199 | 85 | 7 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.10e-07 | 199 | 85 | 7 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.10e-07 | 199 | 85 | 7 | 616c04b0605907fb218263f2164c36cb2fa26b87 | |
| ToppCell | distal-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-07 | 200 | 85 | 7 | 0cd3b01fb7f579e5abf000adb8ec8adc7cd779c4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.14e-07 | 200 | 85 | 7 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-07 | 200 | 85 | 7 | 87e293c0882e2754756a2210a6c04723dc89f81b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.14e-07 | 200 | 85 | 7 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.14e-07 | 200 | 85 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LAM-Myeloid-pMacrophage|LAM / Condition, Lineage and Cell class | 1.14e-07 | 200 | 85 | 7 | 7e233d037165c9d3607604aaaf0f368e266567d3 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.14e-07 | 200 | 85 | 7 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-07 | 200 | 85 | 7 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|COVID-19 / Condition, Lineage and Cell class | 1.14e-07 | 200 | 85 | 7 | b239c711cce967826432fdbd5f88eba98a88bb0c | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 1.14e-07 | 200 | 85 | 7 | 4556bb626ca1a00a6db13d2adb35acb8ba848f9c | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.14e-07 | 200 | 85 | 7 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors|Liver / Manually curated celltypes from each tissue | 7.92e-07 | 166 | 85 | 6 | ae967570248cf86ca3ddf55e33bcbb3e4e3684bc | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Liver / Manually curated celltypes from each tissue | 7.92e-07 | 166 | 85 | 6 | a176e87aa6eec81d1fb79a028f759182d11b567d | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 8.79e-07 | 169 | 85 | 6 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.79e-07 | 169 | 85 | 6 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 8.79e-07 | 169 | 85 | 6 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.42e-07 | 171 | 85 | 6 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-06 | 174 | 85 | 6 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | NS-critical-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.11e-06 | 176 | 85 | 6 | 7cf1a06ceee1ec06532f44c729c31b4d58e5ea49 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.19e-06 | 178 | 85 | 6 | dbde3305e0c6a81593fe614e3f2e746b32cc16a7 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-06 | 180 | 85 | 6 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-06 | 182 | 85 | 6 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease group and Cell class | 1.40e-06 | 183 | 85 | 6 | 09c2b4e630f1c338f02c1242e3598e870d6b0a28 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.44e-06 | 184 | 85 | 6 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-06 | 185 | 85 | 6 | 57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|bone_marrow / Manually curated celltypes from each tissue | 1.54e-06 | 186 | 85 | 6 | e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-06 | 189 | 85 | 6 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-06 | 189 | 85 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 1.74e-06 | 190 | 85 | 6 | 451eaceb0cb0ec6cfcae00253c0e5c92a168c2f3 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-Cycling_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.79e-06 | 191 | 85 | 6 | 5d4fed25bd318472a17228b12ade4c331865bda5 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-06 | 191 | 85 | 6 | d6e158f16a183c9203c057192342e9b83e79bc89 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-06 | 191 | 85 | 6 | 7cb5c6f2cf27f3503d1b313e402a7410dfe6473e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 1.79e-06 | 191 | 85 | 6 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 1.90e-06 | 193 | 85 | 6 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.90e-06 | 193 | 85 | 6 | 81e6240cffb094b2aa3684fd0889b6497f47c4f0 | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.90e-06 | 193 | 85 | 6 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.96e-06 | 194 | 85 | 6 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 1.96e-06 | 194 | 85 | 6 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 194 | 85 | 6 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.96e-06 | 194 | 85 | 6 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.96e-06 | 194 | 85 | 6 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 194 | 85 | 6 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.96e-06 | 194 | 85 | 6 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.96e-06 | 194 | 85 | 6 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-06 | 194 | 85 | 6 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.02e-06 | 195 | 85 | 6 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.02e-06 | 195 | 85 | 6 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | Influenza_Severe-T/NK_proliferative|World / Disease group and Cell class | 2.02e-06 | 195 | 85 | 6 | 6f079c2d7d08110a5e1822ea861b8037eb3f62c9 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.02e-06 | 195 | 85 | 6 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 195 | 85 | 6 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 2.02e-06 | 195 | 85 | 6 | 578bbb06a5476c08fc3b351cc580c551dfe53ae4 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-06 | 196 | 85 | 6 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.08e-06 | 196 | 85 | 6 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.08e-06 | 196 | 85 | 6 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | 2.14e-06 | 197 | 85 | 6 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.14e-06 | 197 | 85 | 6 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 2.14e-06 | 197 | 85 | 6 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.14e-06 | 197 | 85 | 6 | 0b1fa881abbfcc54b322fc27124db3f8947af016 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-06 | 197 | 85 | 6 | 7eb4c1cffd0366204af7e63adc8f751685601a94 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-06 | 197 | 85 | 6 | 2a89a724e8c15a5bb167fdad7eed31444d8c3d68 | |
| ToppCell | proximal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.14e-06 | 197 | 85 | 6 | 0dd9058aa19d1268ebba9a65555870224b5a5978 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.14e-06 | 197 | 85 | 6 | 9243617b307acf3df40d93c41cd8d4788699a7ea | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 2.14e-06 | 197 | 85 | 6 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 2.21e-06 | 198 | 85 | 6 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 2.21e-06 | 198 | 85 | 6 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.21e-06 | 198 | 85 | 6 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 2.21e-06 | 198 | 85 | 6 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.21e-06 | 198 | 85 | 6 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.21e-06 | 198 | 85 | 6 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.21e-06 | 198 | 85 | 6 | 50f236ab7ef6f00721f6cd714e3eee183077beeb | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.21e-06 | 198 | 85 | 6 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 7.70e-06 | 192 | 85 | 7 | 4144_DN | |
| Drug | Hecogenin [467-55-0]; Down 200; 9.2uM; HL60; HT_HG-U133A | 9.11e-06 | 197 | 85 | 7 | 2716_DN | |
| Drug | swinholide A | 1.38e-05 | 2 | 85 | 2 | ctd:C086235 | |
| Drug | isocamphane | 1.38e-05 | 2 | 85 | 2 | CID000296894 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 2.07e-08 | 3 | 82 | 3 | DOID:0080463 (implicated_via_orthology) | |
| Disease | stearoyl sphingomyelin (d18:1/18:0) measurement | 1.14e-04 | 6 | 82 | 2 | EFO_0800611 | |
| Disease | Neurodevelopmental Disorders | 1.34e-04 | 93 | 82 | 4 | C1535926 | |
| Disease | Neuroblastoma | 3.07e-04 | 47 | 82 | 3 | C0027819 | |
| Disease | ovarian cancer (is_implicated_in) | 5.16e-04 | 56 | 82 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | Paroxysmal atrial fibrillation | 9.54e-04 | 156 | 82 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 9.54e-04 | 156 | 82 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 9.54e-04 | 156 | 82 | 4 | C2585653 | |
| Disease | Malignant Glioma | 9.90e-04 | 70 | 82 | 3 | C0555198 | |
| Disease | mixed gliomas | 9.90e-04 | 70 | 82 | 3 | C0259783 | |
| Disease | Atrial Fibrillation | 1.05e-03 | 160 | 82 | 4 | C0004238 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.13e-03 | 18 | 82 | 2 | HP_0002373 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.46e-03 | 80 | 82 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | Joubert syndrome 1 | 1.55e-03 | 21 | 82 | 2 | C4551568 | |
| Disease | X-12063 measurement | 1.82e-03 | 186 | 82 | 4 | EFO_0021283 | |
| Disease | Glioma | 1.85e-03 | 87 | 82 | 3 | C0017638 | |
| Disease | Carcinoma of lung | 1.86e-03 | 23 | 82 | 2 | C0684249 | |
| Disease | apolipoprotein B measurement | 2.48e-03 | 663 | 82 | 7 | EFO_0004615 | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.63e-03 | 670 | 82 | 7 | EFO_0006335, EFO_0006336 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 2.75e-03 | 28 | 82 | 2 | DOID:3717 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESTDSGNTHQTHMEE | 451 | A8MVM7 | |
| MIDSHEKTISEDGNH | 146 | Q86Y25 | |
| TATADDTHKLDHINM | 751 | Q96RT1 | |
| TAEHFQEAMEESKTH | 131 | Q9BRK5 | |
| THSEMRKEQSHEDQG | 1161 | Q8N157 | |
| SDVMTHENFHKKNTQ | 566 | Q86V15 | |
| HSHTLQEVKMTVQED | 156 | P10144 | |
| MNTKDTTEVAENSHH | 1 | O94983 | |
| HQHSNSMDNLDSECS | 336 | Q69YQ0 | |
| TTEHIQTHFESKMEI | 1896 | Q8NFD5 | |
| MNSENSHSHEEEKDL | 896 | Q9UPS8 | |
| ESMEIHATGKHSESN | 1881 | Q9P2D1 | |
| SVLQEKHTTEHEMSI | 331 | Q8WWL7 | |
| NEMTTTDDLDFKHHN | 306 | Q8N436 | |
| QETLPSKSNESHDHM | 71 | P10451 | |
| KVMSHSGDSHEESQT | 331 | Q7Z6M1 | |
| KHETSTVQKSMFHDV | 446 | Q9UPP5 | |
| SMTAKEHHKEQEEVS | 426 | M0R2J8 | |
| EATGHTNEMKHTTDF | 131 | O95278 | |
| SNKDDEENSMHNTVV | 931 | Q8NEZ4 | |
| STDMHHIEESFQEIK | 31 | Q9UHD0 | |
| EAMNAHSEESKGTHE | 631 | O60303 | |
| LHHSNGEEKAQSMET | 56 | Q10471 | |
| HMSKNHDVAQSEIRA | 2491 | Q15751 | |
| SSKSMHNVTHNLEED | 706 | Q5T0W9 | |
| DHDIDMKSEQSHVEQ | 591 | Q14149 | |
| HKAQTNEALKSTAHM | 41 | Q6UXP7 | |
| SQVHASTDQEIQEMH | 1306 | Q9HD67 | |
| TKNRHMATTQDEVHT | 1261 | O60449 | |
| SASSTHQMHVSLKED | 276 | Q8NG31 | |
| MENHNHSKESHTLQV | 106 | Q30201 | |
| ENHTHHITSAKMAVS | 506 | Q7Z3K6 | |
| SQEKVMNDSDTHENS | 1451 | P23471 | |
| DHAMSVASDHNVKEF | 896 | Q9Y5B6 | |
| ATHLKQTMSHDSQAV | 176 | P34949 | |
| SAENTMVAHHIVENT | 226 | Q05DH4 | |
| THSAADEEVKNIMSS | 911 | Q8NF50 | |
| HDSVVSMFKIENHND | 1266 | P51587 | |
| TTEVKSVEMHHEALS | 286 | Q05639 | |
| TTEVKSVEMHHEALS | 286 | P68104 | |
| SDSQSHMHSVNVEEI | 901 | Q0VDD8 | |
| FEHNDAMTEKSHQSA | 1176 | Q99698 | |
| TTEVKSVEMHHEALS | 286 | Q5VTE0 | |
| NHTENDVTHLQKEMS | 616 | Q9BXX0 | |
| SNITNMHQDKETSDA | 826 | Q8NDH2 | |
| EVSVKSDDKHMHDHN | 161 | Q9ULF5 | |
| QDKEQHTMPLTHTAD | 91 | Q96RY7 | |
| HHTQEEDISSKMASV | 761 | Q2NKX8 | |
| KVNDTDVTNMTHTDA | 1836 | Q12923 | |
| NTVDTSHEDMIHDAQ | 6 | P55735 | |
| SESSQMTEHRKVSDH | 796 | Q6P4F7 | |
| SSTEDSLHVHAQMAE | 606 | Q6ZMZ0 | |
| SQHTHCAQDLAMKDE | 741 | Q96R06 | |
| EHSTHMENQAVVCKE | 1556 | A2VDJ0 | |
| SHHASTVQMALEDSE | 3821 | Q8WXH0 | |
| QSHLKASEHAADIQM | 316 | O43426 | |
| SHKSFETNAQEDTME | 541 | Q86VH5 | |
| LLSSHMDQKDDHQSS | 616 | Q6T4R5 | |
| VEEQRKMSQDSVHHT | 276 | O75563 | |
| NQVHLSESTMEHDNT | 1341 | Q5UIP0 | |
| IDMDTVHDSQAFISH | 1046 | Q6P1X5 | |
| HNEKEQEMTSPVSHS | 1116 | Q96PQ0 | |
| MDHLNEATQGKEHSE | 1 | Q01826 | |
| QDHSHSEQDDSSEKM | 61 | Q8WXE9 | |
| ANTTEMNSDHHSKGS | 351 | Q9HAW4 | |
| RHTDAHNKIQEESDM | 16 | Q6ZUT1 | |
| DVGNLVSKHMNETSH | 231 | Q16620 | |
| VSKHMNETSHTQGSL | 236 | Q16620 | |
| HVVATSQSKTMGHQD | 241 | A6NDS4 | |
| TEMVSHLEKHTEEVN | 146 | A4UGR9 | |
| HQKSTTVSHEMSGLN | 26 | O95258 | |
| ESSNLTTHKMIHTGE | 411 | Q8TF32 | |
| FQSHMSQASEESAHK | 956 | Q9ULJ3 | |
| THMITHIGEKTSEDN | 131 | Q147U1 | |
| TATHSVHEEKMTNGQ | 671 | Q9NXZ1 | |
| METSAQSSGDHQEQH | 1456 | P12270 | |
| DMEHSTVKESVSTNN | 291 | Q99592 | |
| MDQHQHLNKTAESAS | 1 | Q9NPD5 | |
| DTMDVENNSTLEKHS | 516 | P23497 | |
| DSVMNHHLQETSFTK | 76 | Q56UQ5 | |
| MHTTESKNEHLEDEN | 1 | Q4ZJI4 | |
| HHISQSEGQRTKEEM | 351 | Q6P444 | |
| MNKAAHQESTEHVLS | 331 | Q8TAD4 | |
| QHTHDAITEAAQLMK | 1791 | Q9Y4G6 | |
| VSHNDMKTESTTDEA | 491 | Q5TAH2 | |
| DLLQDSQVHDSHMSE | 501 | P52739 | |
| HMQSTFDNTIKEHFT | 216 | Q3SY77 | |
| THQQTHTEEKSYMCS | 276 | Q8N883 | |
| LTHFKETQTHENMSQ | 696 | Q9BWU0 |